Zymeworks ZYME Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's common stock, shares authorized (in shares)?
- Zymeworks (ZYME) reported common stock, shares authorized (in shares) of $900M in Q1 2026.
- How has Zymeworks's common stock, shares authorized (in shares) changed year-over-year?
- Zymeworks's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $900M to $900M.
- What is the long-term trend for Zymeworks's common stock, shares authorized (in shares)?
- Over 3 years (2022 to 2025), Zymeworks's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $900M to $900M.